A Review of Autologous Stem Cell Transplantation in Lymphoma
Umar Zahid
1, 2
,
Faisal Akbar
3
,
Akshay Amaraneni
4
,
Muhammad Husnain
5
,
Onyee Chan
5
,
Irbaz bin Riaz
1
,
McBride Ali
6
,
Iftikhar Ahmad
7
,
Faiz Anwer
8, 9
3
Department of Medicine, Wake Forest Baptist Medical Center, Winston Salem, USA
|
Publication type: Journal Article
Publication date: 2017-05-06
scimago Q1
wos Q2
SJR: 1.123
CiteScore: 5.9
Impact factor: 3.3
ISSN: 15588211, 1558822X
PubMed ID:
28478586
Cancer Research
Oncology
Hematology
Abstract
Chemotherapy remains the first-line therapy for aggressive lymphomas. However, 20–30% of patients with non-Hodgkin lymphoma (NHL) and 15% with Hodgkin lymphoma (HL) recur after initial therapy. We want to explore the role of high-dose chemotherapy (HDT) and autologous stem cell transplant (ASCT) for these patients. There is some utility of upfront consolidation for-high risk/high-grade B-cell lymphoma, mantle cell lymphoma, and T-cell lymphoma, but there is no role of similar intervention for HL. New conditioning regimens are being investigated which have demonstrated an improved safety profile without compromising the myeloablative efficiency for relapsed or refractory HL. Salvage chemotherapy followed by HDT and rescue autologous stem cell transplant remains the standard of care for relapsed/refractory lymphoma. The role of novel agents to improve disease-related parameters remains to be elucidated in frontline induction, disease salvage, and high-dose consolidation or in the maintenance setting.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
|
|
|
Transfusion and Apheresis Science
4 publications, 4.71%
|
|
|
Annals of Hematology
3 publications, 3.53%
|
|
|
Cytotherapy
3 publications, 3.53%
|
|
|
Leukemia and Lymphoma
3 publications, 3.53%
|
|
|
Cell Transplantation
2 publications, 2.35%
|
|
|
International Journal of Hematology
2 publications, 2.35%
|
|
|
Bone Marrow Transplantation
2 publications, 2.35%
|
|
|
Supportive Care in Cancer
2 publications, 2.35%
|
|
|
Clinical Lymphoma, Myeloma and Leukemia
2 publications, 2.35%
|
|
|
Transplantation and Cellular Therapy
2 publications, 2.35%
|
|
|
New England Journal of Medicine
1 publication, 1.18%
|
|
|
JCI insight
1 publication, 1.18%
|
|
|
Journal of Biomedical Nanotechnology
1 publication, 1.18%
|
|
|
Anti-Cancer Agents in Medicinal Chemistry
1 publication, 1.18%
|
|
|
Journal of VitreoRetinal Diseases
1 publication, 1.18%
|
|
|
International Journal of Molecular Sciences
1 publication, 1.18%
|
|
|
Journal of Personalized Medicine
1 publication, 1.18%
|
|
|
Frontiers in Endocrinology
1 publication, 1.18%
|
|
|
Nature Communications
1 publication, 1.18%
|
|
|
Clinical Hematology International
1 publication, 1.18%
|
|
|
Hematology, Transfusion and Cell Therapy
1 publication, 1.18%
|
|
|
BMC Cancer
1 publication, 1.18%
|
|
|
Journal of Controlled Release
1 publication, 1.18%
|
|
|
Blood Reviews
1 publication, 1.18%
|
|
|
International Immunopharmacology
1 publication, 1.18%
|
|
|
European Journal of Oncology Nursing
1 publication, 1.18%
|
|
|
Transplant Infectious Disease
1 publication, 1.18%
|
|
|
Journal of Ultrasound in Medicine
1 publication, 1.18%
|
|
|
Lab on a Chip
1 publication, 1.18%
|
|
|
1
2
3
4
|
Publishers
|
5
10
15
20
25
|
|
|
Elsevier
21 publications, 24.71%
|
|
|
Springer Nature
19 publications, 22.35%
|
|
|
Wiley
8 publications, 9.41%
|
|
|
MDPI
6 publications, 7.06%
|
|
|
SAGE
4 publications, 4.71%
|
|
|
Taylor & Francis
4 publications, 4.71%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 2.35%
|
|
|
Frontiers Media S.A.
2 publications, 2.35%
|
|
|
Massachusetts Medical Society
1 publication, 1.18%
|
|
|
American Society for Clinical Investigation
1 publication, 1.18%
|
|
|
American Scientific Publishers
1 publication, 1.18%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 1.18%
|
|
|
BMJ
1 publication, 1.18%
|
|
|
American Medical Association (AMA)
1 publication, 1.18%
|
|
|
King Faisal Specialist Hospital and Research Centre
1 publication, 1.18%
|
|
|
Hindawi Limited
1 publication, 1.18%
|
|
|
American Society of Hematology
1 publication, 1.18%
|
|
|
Hans Publishers
1 publication, 1.18%
|
|
|
Spandidos Publications
1 publication, 1.18%
|
|
|
Medknow
1 publication, 1.18%
|
|
|
Centre for Evaluation in Education and Science (CEON/CEES)
1 publication, 1.18%
|
|
|
Research Square Platform LLC
1 publication, 1.18%
|
|
|
S. Karger AG
1 publication, 1.18%
|
|
|
American Society of Clinical Oncology (ASCO)
1 publication, 1.18%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 1.18%
|
|
|
Apex Publishing
1 publication, 1.18%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
85
Total citations:
85
Citations from 2024:
25
(29.41%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Zahid U. et al. A Review of Autologous Stem Cell Transplantation in Lymphoma // Current Hematologic Malignancy Reports. 2017. Vol. 12. No. 3. pp. 217-226.
GOST all authors (up to 50)
Copy
Zahid U., Akbar F., Amaraneni A., Husnain M., Chan O., Riaz I. B., Ali M., Ahmad I., Anwer F. A Review of Autologous Stem Cell Transplantation in Lymphoma // Current Hematologic Malignancy Reports. 2017. Vol. 12. No. 3. pp. 217-226.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1007/s11899-017-0382-1
UR - https://doi.org/10.1007/s11899-017-0382-1
TI - A Review of Autologous Stem Cell Transplantation in Lymphoma
T2 - Current Hematologic Malignancy Reports
AU - Zahid, Umar
AU - Akbar, Faisal
AU - Amaraneni, Akshay
AU - Husnain, Muhammad
AU - Chan, Onyee
AU - Riaz, Irbaz bin
AU - Ali, McBride
AU - Ahmad, Iftikhar
AU - Anwer, Faiz
PY - 2017
DA - 2017/05/06
PB - Springer Nature
SP - 217-226
IS - 3
VL - 12
PMID - 28478586
SN - 1558-8211
SN - 1558-822X
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2017_Zahid,
author = {Umar Zahid and Faisal Akbar and Akshay Amaraneni and Muhammad Husnain and Onyee Chan and Irbaz bin Riaz and McBride Ali and Iftikhar Ahmad and Faiz Anwer},
title = {A Review of Autologous Stem Cell Transplantation in Lymphoma},
journal = {Current Hematologic Malignancy Reports},
year = {2017},
volume = {12},
publisher = {Springer Nature},
month = {may},
url = {https://doi.org/10.1007/s11899-017-0382-1},
number = {3},
pages = {217--226},
doi = {10.1007/s11899-017-0382-1}
}
Cite this
MLA
Copy
Zahid, Umar, et al. “A Review of Autologous Stem Cell Transplantation in Lymphoma.” Current Hematologic Malignancy Reports, vol. 12, no. 3, May. 2017, pp. 217-226. https://doi.org/10.1007/s11899-017-0382-1.